Neos Therapeutics Reports Second Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/3/2026
- Wall St futures subdued as investors weigh earnings, oil prices
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Snowflake soars 20% on earnings beat and raised guidance
- Oil settles 1% higher, as US-Iran strikes threaten supplies
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
Neos Therapeutics (NEOS) Tops Q2 EPS by 2c
August 10, 2020 7:10 AM EDTNeos Therapeutics (NASDAQ: NEOS) reported Q2 EPS of ($0.11), $0.02 better than the analyst estimate of ($0.13). Revenue for the quarter came in at $13.1 million versus the consensus estimate of $12.17 million.
For earnings history and earnings-related data on Neos Therapeutics (NEOS) click here.
... More